Ajanta Pharma shares touched a high of Rs 2,784.80, up 3.52 percent. The scrip has risen for the last two trading sessions.

Ajanta Pharma shares gained 3% despite a weak market as analysts turned bullish on its Biocon partnership, semaglutide ...

According to PL Capital, Ajanta Pharma's strong franchise will aid in garnering a higher market share for semaglutide ...

Indian drugmaker Biocon has announced the signing of an out-licensing agreement with Ajanta Pharma to market its vertically ...

Ajanta Pharma secures exclusive rights to market Biocon's semaglutide in 26 countries, targeting growth in diabetes and ...

Ajanta Pharma shares were trading in green during Tuesday's intraday trade. Ajanta Pharma shares had touched a 52-week high ...

Yogesh Agrawal, MD of Ajanta Pharma outlined Ajanta Pharma’s strategy to capitalise on the opportunity through its ...

Ajanta Pharma has entered a consolidation phase in FY26 due to incremental investments in MRs for both base and newer ...

Ajanta Pharma plans to sell generic semaglutide in 26 countries, in a partnership with Biocon, capitalizing on patent ...

AJANTA, India -- From the top of a cliff in the Sahyadri range of the Western Ghats, India's largest watershed, lush green forests stretch out on all sides, providing a verdant panorama as far as the ...

INSV Kaundinya, the Indian Navy’s stitched sailing vessel recreated from depictions of ancient Indian ships in Ajanta Cave ...

During her 15-day journey, the ship will retrace ancient maritime routes that once connected India with West Asia and the ...